Fortune MNC 500 India 2026 edition
Rank#366- Total income
- ₹973 Cr
- Profit
- ₹37 Cr
Last year #353
Please enter your name.
Please enter a valid email address.
Please select an issue type.
Please add a few details about the issue.
About Kores
Kores is a Healthcare company based in Mumbai (India) founded in 1932. Diversified operations in office products, pharmaceuticals, and engineering are conducted. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. The company has 817 employees. Its chief executive, as recorded, is Sunil Pudi. Its Indian entity Kores (India) Limited reported revenue of ₹835 Cr. Kores offers products and services including Stationery Products, Engineering Solutions, Foundry Castings, Business Automation, and Pharmaceutical Drugs. Its focus areas include Industrials, Diversified Industrials, Conglomerates and Consumer Goods. Similar companies include Laurus Labs, Symbiotec and Jubilant Pharma; 2 of its 3 listed similar companies have raised funding.
Company details
Kores is established as a diversified conglomerate with a global presence, operating across multiple industries including stationery, engineering, foundry, business automation, and pharmaceuticals. Products and services are provided to both domestic and international markets. Solutions such as core drilling equipment, high-quality metal castings, and life-changing drugs are developed. Business automation tools are offered to unlock company potential. The commitment to innovation, collaboration, and excellence is maintained to ensure a positive impact on lives.
Kores is ranked #366 on the Fortune MNC 500 India (2026).
Recognitions & Rankings of Kores
- Headquarters Mumbai, India
- Employees 817
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kores.in
- Social LinkedIn Facebook Instagram
- Legal Name Kores India Ltd.
- Date of Incorporation 26 May, 1936
- Jurisdiction Mumbai, Maharashtra, India
Operational Areas
Key Metrics
- Annual Revenue₹835 Cr
FY 2023 · +24% YoY
- Net Profit₹26.82 Cr
FY 2023 · 3% margin
- EBITDA₹66.54 Cr
FY 2023 · 7% margin
- Employee Count817
Associated legal entities of Kores
Kores operates through Kores (India) Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kores (India) Limited CIN U21198MH1936PLC002494 | Active | 26 May 1936 | Mumbai, Maharashtra | ₹835 Cr | 817 | 11 | View details |
Products & Services of Kores
Kores offers a comprehensive portfolio of products and services, including Stationery Products, Engineering Solutions, Foundry Castings, Business Automation, and Pharmaceutical Drugs.
Stationery Products
Stationery
Stationery products are offered for domestic and global markets.
Engineering Solutions
Engineering
Core drilling solutions are provided for various project needs.
Foundry Castings
Foundry
High-quality metal castings are crafted for multiple industries.
Business Automation
Automation
Automation solutions are delivered to enhance company potential.
Pharmaceutical Drugs
Pharmaceuticals
Life-changing drugs are developed for patient health improvement.
Board of directors of Kores (India) Limited (Kores)
Kores (India) Limited is the primary company behind Kores. The board of Kores (India) Limited currently have 9 directors; the longest-serving is Anand Kumar Thirani, appointed in 1981. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anand Kumar Thirani DIN 00082344 | Managing Director | 29 May 1981 | 45 yrs 4 mo | Kores (India) Limited |
| Rajkumar Hanumanprasad Saboo DIN 00053600 | Whole-time director | 01 Apr 2005 | 21 yrs 6 mo | Kores (India) Limited |
| Vivek Prakash Bagri DIN 03527490 | Director | 17 May 2013 | 13 yrs 5 mo | Kores (India) Limited |
| Nandini Sameer Mehta DIN 06934986 | Whole-time director | 17 Jul 2014 | 12 yrs 3 mo | Kores (India) Limited |
| Jagdish Prasad Gupta DIN 00053681 | Director | 17 Jul 2014 | 12 yrs 3 mo | Kores (India) Limited |
| Rekha Anand Thirani DIN 00054058 | Director | 15 Nov 2016 | 9 yrs 11 mo | Kores (India) Limited |
| Ashoke Banerjee DIN 00273635 | Director | 14 Mar 2017 | 9 yrs 7 mo | Kores (India) Limited |
| Ajay Kumar Dhagat DIN 00250792 | Director | 19 Mar 2019 | 7 yrs 7 mo | Kores (India) Limited |
| Neha Thirani Bagri DIN 10723962 | Additional Director | 25 Jul 2024 | 2 yrs 3 mo | Kores (India) Limited |
People of Kores
2 people are tracked at Kores (2 in leadership); the tracked headcount is 817.
| Name | Role | Group |
|---|---|---|
Sunil Pudi | Co-CEO | Leadership |
Harshal Dunakhe | Co-CEO | Leadership |
Premium access
Complete people profiles for Kores
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Kores
Figures of Kores (India) Limited, the primary company behind Kores, for FY 2023. Revenue was ₹835 Cr (+24% year on year). Net profit was ₹26.82 Cr (3% margin). EBITDA was ₹66.54 Cr (7% margin). Revenue has grown at a compounded annual rate of +16% over three years and +7% over five years.
- ₹835 CrRevenue · FY 2023 · +24% YoY
- ₹26.82 CrNet profit · 3% margin
- ₹66.54 CrEBITDA · 7% margin
- ₹12.84 CrPaid-up capital
- 817Employees (provident fund records)
- +16%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kores (India) Limited are on its company page.
Premium access
Detailed financial statements for Kores
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Kores
Kores has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and Jubilant Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| jubilantpharma.com | 1978 | Noida, India | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. |
Premium access
Detailed similar companies of Kores
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kores
The website of Kores (kores.in) receives about 4.7K visits a month.
- Monthly visits4.7K
▲ 69.7% vs previous month
Similar websites
Websites whose visitors overlap most with Kores. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
paperfine.com | paperfine.com | 100% | – | ||
kores-india.com | kores-india.com | 99% | – | ||
atijsr.com | atijsr.com | 64% | #6,409,080 | – | |
spcollegehilsa.in | spcollegehilsa.in | 62% | #6,707,540 | – | |
| jmcjammu.org | 56% | #4,194,821 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
Premium access
All 8 similar websites and full traffic analytics for Kores
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Kores (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Upgrade to premium
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kores
Kores was founded in 1932.
Kores is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Sunil Pudi is the CEO of Kores, as recorded in our data.
Kores has 817 employees.
The primary company behind Kores, Kores (India) Limited, reported revenue of ₹835 Cr for FY 2023, up 24% year on year.
Kores is established as a diversified conglomerate with a global presence, operating across multiple industries including stationery, engineering, foundry, business automation, and pharmaceuticals. Products and services are provided to both domestic and international markets. Solutions such as core drilling equipment, high-quality metal castings, and life-changing drugs are developed. Business automation tools are offered to unlock company potential. The commitment to innovation, collaboration, and excellence is maintained to ensure a positive impact on lives.
Kores's top competitors include Laurus Labs, Symbiotec and Jubilant Pharma.
Kores offers Stationery Products, Engineering Solutions, Foundry Castings, Business Automation, and Pharmaceutical Drugs.
Kores operates through Kores (India) Limited.
The legal entities of Kores currently have 11 directors, including Nandini Sameer Mehta, Vivek Prakash Bagri, Rajkumar Hanumanprasad Saboo and others.